Insights

Ascelia Pharma AB

Nasdaq Stockholm · LEI 5493002YR9VCJJPWYN08· Fiscal year 2025

Staff cost per employee
Not disclosed
Employees
Not disclosed

Quick read

  • Operating loss of $7.3M in 2025.

Last 3 years

Revenue
$02024$02025
Operating income
-$6.7M2024-$7.3M2025

See the share price on Google Finance ↗

Investor metrics

2025
ROE
-76.7%
Debt-to-equity
12.5%
Equity ratio
88.9%

USD at SEK 10.18 per $1 (2026-11-20, ExchangeRate-API)

Staff costs from the annual report (wages, social charges, pensions) divided by the average number of employees. Usually higher than take-home pay.

audited consolidated financial statements · View the annual report (filings.xbrl.org)

Not investment advice. Figures come from public filings and may contain errors.